Compared with thrombotic stroke, hemorrhagic stroke has more than double the odds of diagnostic delay in pregnant and postpartum patients.

Among children with high blood pressure (BP), there are racial and ethnic disparities in receipt of nutrition, lifestyle, and weight counseling.

On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.

Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study.

Older age, lower education, and living in a rural area are associated with physical inactivity among stroke survivors.

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

COVID-19 infection, compared with influenza, is associated with increased myocarditis rates among adults in the United States.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

A study has found that, among women with breast cancer, aerobic exercise significantly decreases risk for cardiovascular disease.

The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.